Seth Blackley - Oct 15, 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Executive Officer, Director
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol: EVH
Transactions as of: Oct 15, 2021
Transactions value $: -$3,903,000
Form type: 4
Date filed: 10/19/2021, 09:15 PM
Next filing: Mar 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Options Exercise	$576K	+150K	+73.23%	$3.84^*	355K	Oct 15, 2021	Direct	F1, F2
transaction	EVH	Class A Common Stock	Sale	-$4.48M	-150K	-42.27%	$29.86	205K	Oct 15, 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Class A Common Option (right to buy)	Options Exercise	$0	-150K	-44.64%	$0.00	186K	Oct 15, 2021	Class A Common Stock	150K	$3.84	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021.
F2	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.66 to $30.07, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The Class A Common Stock Options exercised vested on December 1, 2015 and December 1, 2016.